Dr. Bronner’s has advocated for cannabis policy reform since the early 2000s—first focusing on industrial hemp, then pivoting to medical and recreational decriminalization and legalization efforts. We’ve long held that cannabis is a plant that can help heal our people and planet. Unfortunately, big business has moved into states where cannabis had been legalized, seeking to reap big profits and leaving legacy cannabis growers high and dry.
Author: David Bronner and Les Szabo
David Bronner is Cosmic Engagement Officer (CEO) of Dr. Bronner’s, and a board member of MAPS: Multidisciplinary Association for Psychedelic Studies.
Les Szabo is Director of Constructive Capital at Dr. Bronner’s.
Psychedelics at a Crossroads: We Need Constructive Not Extractive Capital
In her recent thoughtful and well-researched article for Vice, Shayla Love asked, “Is it possible to create an ethical psychedelics company?” A lot of focus in the psychedelics space over the last few months has centered around the unethical behavior of select companies—David himself has weighed in. Our take is that it’s not only possible to create an ethical psychedelics company,